News

News
JNJ Press releases

eTheRNA joins the JLINX Community

Read full story
Partner news

Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy

Read full story
JNJ Press releases

Johnson & Johnson Innovation and Janssen Award U.S. $1.5 Million in Grants for World Without Disease QuickFire Challenge

Read full story
Partner news

ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop® Near Vision Inlay

Read full story
Partner news

Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients

Read full story
JNJ Press releases

“Pitch Your Microbes” Competition at the European Microbiome Congress

Read full story
Partner news

BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders

Read full story
JNJ Press releases

JLINX Science Meets Business Symposium

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces New Collaboration with TMC

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces New Collaboration with Texas Medical Center to Spur Development of Breakthrough Medical Device Technologies

Read full story
JNJ Press releases

Johnson & Johnson, Texas Medical Center join forces to develop medical devices in Houston

Read full story
JNJ Press releases

J&J to create new Texas center to develop ‘breakthrough’ med tech

Read full story
Partner news

TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc.

Read full story
Partner news

CVRx® Secures $113 Million in New Financing

Read full story
Partner news

Torax Medical, Inc. Raises $25 Million in Series E Funding and Welcomes New Chief Commercial Officer

Read full story